Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 1.22%234.05M | 73.08%1.05B | 129.49%716.39M | 127.39%416.01M | 180.51%231.22M | 60.84%605.31M | 8.25%312.17M | -2.04%182.94M | -12.37%82.43M | -13.49%376.34M |
Refunds of taxes and levies | -46.92%1.16M | -37.08%35.93M | -35.78%29.35M | -50.85%19.03M | -92.70%2.19M | 194.96%57.11M | 342.76%45.7M | 532.29%38.73M | 1,874.52%30.06M | 1,616.34%19.36M |
Cash received relating to other operating activities | -65.87%7.8M | 15.70%41.85M | 240.30%35.69M | 417.42%30.92M | 4,643.40%22.86M | 92.01%36.17M | -39.13%10.49M | -45.82%5.98M | -71.92%481.84K | -4.11%18.84M |
Cash inflows from operating activities | -5.17%243.01M | 61.11%1.13B | 112.14%781.43M | 104.69%465.96M | 126.85%256.27M | 68.52%698.59M | 16.60%368.35M | 11.65%227.65M | 16.10%112.97M | -9.05%414.54M |
Goods services cash paid | -5.25%72.55M | 29.87%293.24M | 34.66%201.72M | 57.64%137.08M | 98.54%76.56M | 30.50%225.8M | 10.71%149.8M | 4.88%86.95M | -9.74%38.56M | 36.01%173.03M |
Staff behalf paid | 23.28%83.71M | 43.73%314.14M | 53.17%228.92M | 57.83%143.33M | 63.06%67.9M | 50.82%218.56M | 36.57%149.45M | 24.10%90.81M | 16.17%41.64M | 40.09%144.92M |
All taxes paid | 65.07%6.94M | 65.76%9.56M | 15.47%6.15M | 117.74%4.66M | 138.65%4.2M | -33.96%5.77M | -37.66%5.33M | -74.28%2.14M | -57.53%1.76M | -71.48%8.73M |
Cash paid relating to other operating activities | 26.55%5.04M | -17.46%19.94M | -3.46%16.18M | 4.54%10.77M | -30.31%3.98M | 11.53%24.16M | 26.87%16.76M | 41.63%10.3M | 72.03%5.72M | 13.82%21.66M |
Cash outflows from operating activities | 10.21%168.24M | 34.28%636.88M | 40.97%452.97M | 55.53%295.83M | 74.10%152.65M | 36.16%474.28M | 20.58%321.33M | 10.80%190.2M | 1.91%87.68M | 24.27%348.33M |
Net cash flows from operating activities | -27.83%74.78M | 117.82%488.61M | 598.55%328.47M | 354.38%170.14M | 309.78%103.61M | 238.80%224.32M | -4.88%47.02M | 16.18%37.44M | 124.46%25.29M | -62.27%66.21M |
Investing cash flow | ||||||||||
Cash received from returns on investments | -99.07%220.24K | 15.80%27M | 24.82%24.82M | 19.38%23.74M | 19.65%23.66M | 0.14%23.32M | 152.48%19.89M | 304.88%19.89M | 1,044.03%19.77M | 434.03%23.29M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 540.21%779.16K | ---- | ---- | ---- | -49.92%121.7K | ---- | ---- | ---- | 247.14%243K |
Cash received relating to other investing activities | -89.31%30.54M | 43.84%424.93M | 53.87%406.64M | 58.52%395.77M | 39.85%285.77M | -24.47%295.42M | 40.35%264.27M | 96.53%249.67M | 345.39%204.34M | -22.82%391.13M |
Cash inflows from investing activities | -90.06%30.76M | 41.98%452.71M | 51.84%431.46M | 55.63%419.52M | 38.07%309.43M | -23.10%318.86M | 44.68%284.15M | 103.91%269.56M | 368.39%224.11M | -18.89%414.66M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -51.79%85.7M | 18.88%480.52M | 33.71%378.68M | 38.29%284.16M | 185.22%177.79M | 18.86%404.21M | 49.85%283.22M | 100.96%205.48M | 6.76%62.33M | 219.20%340.08M |
Cash paid to acquire investments | ---- | --16.5M | --16.5M | --16.5M | --16.5M | ---- | ---- | ---- | ---- | ---- |
Cash paid relating to other investing activities | -44.74%60.92M | 93.98%176.05M | 35.85%121.41M | 47.89%121.31M | 35.24%110.23M | -47.27%90.76M | 30.00%89.37M | 159.18%82.03M | 293.67%81.51M | -66.59%172.11M |
Cash outflows from investing activities | -51.85%146.62M | 35.98%673.07M | 38.65%516.59M | 46.77%421.97M | 111.70%304.52M | -3.36%494.96M | 44.56%372.59M | 114.72%287.51M | 81.87%143.84M | -17.61%512.19M |
Net cash flows from investing activities | -2,458.96%-115.87M | -25.13%-220.35M | 3.74%-85.13M | 86.34%-2.45M | -93.88%4.91M | -80.57%-176.1M | -44.17%-88.43M | -949.61%-17.95M | 356.89%80.27M | 11.66%-97.53M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | --13.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from borrowing | -14.72%3.41M | -83.69%44.1M | -75.47%41.08M | -38.18%34M | -80.00%4M | 125.77%270.48M | 236.28%167.47M | --55M | --20M | --119.8M |
Cash inflows from financing activities | -14.72%3.41M | -78.71%57.58M | -75.47%41.08M | -38.18%34M | -80.00%4M | 125.77%270.48M | 236.28%167.47M | --55M | --20M | 689.20%119.8M |
Borrowing repayment | -75.50%4.9M | 123.02%289.48M | 237.36%235.48M | 350.69%180.28M | 0.00%20M | --129.8M | --69.8M | --40M | --20M | ---- |
Dividend interest payment | -92.35%151.41K | 30.19%84.99M | 2,565.81%84.45M | 4,167.29%83.58M | 96.41%1.98M | 7.16%65.29M | -94.75%3.17M | -96.56%1.96M | --1.01M | 1.13%60.92M |
Cash payments relating to other financing activities | ---- | ---- | ---- | ---- | ---- | 46.41%9.25M | --9.25M | --9.25M | ---- | 6,920.24%6.32M |
Cash outflows from financing activities | -77.02%5.05M | 83.26%374.47M | 289.12%319.93M | 415.25%263.86M | 4.62%21.98M | 203.89%204.34M | 36.18%82.22M | -10.04%51.21M | --21.01M | 11.45%67.24M |
Net cash flows from financing activities | 90.88%-1.64M | -579.12%-316.89M | -427.09%-278.85M | -6,164.01%-229.86M | -1,684.79%-17.98M | 25.83%66.14M | 906.27%85.25M | 106.66%3.79M | ---1.01M | 216.41%52.56M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 4.64%2.2M | 201.61%6.57M | 226.93%3.74M | 510.46%4.64M | 1,145.11%2.11M | 64.02%2.18M | 6.58%1.15M | 5.47%759.65K | -70.59%-201.61K | 293.36%1.33M |
Net increase in cash and cash equivalents | -143.74%-40.53M | -136.09%-42.05M | -170.62%-31.76M | -339.34%-57.54M | -11.20%92.65M | 416.28%116.53M | 310.11%44.98M | 193.60%24.04M | 619.16%104.34M | 17.31%22.57M |
Add:Begin period cash and cash equivalents | -20.75%160.61M | 135.29%202.67M | 135.29%202.67M | 135.29%202.67M | 135.29%202.67M | 35.51%86.13M | 35.51%86.13M | 35.51%86.13M | 35.51%86.13M | 43.41%63.56M |
End period cash equivalent | -59.34%120.08M | -20.75%160.61M | 30.35%170.9M | 31.73%145.13M | 55.04%295.32M | 135.29%202.67M | 211.04%131.11M | 190.86%110.17M | 338.25%190.48M | 35.51%86.13M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.